Getafe Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2007
NCT00448903
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Getafe Hospital, E-28905 Getafe (Madrid) Spain

Active Ingredients

Drugs in Phase 3 Trials (1)

enoxaparin (lovenox) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Foot (Phase 3)

Foot Ulcer (Phase 3)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1